Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains
about
Kynurenines in CNS disease: regulation by inflammatory cytokinesSpecific transfection of inflamed brain by macrophages: a new therapeutic strategy for neurodegenerative diseasesGene therapy in Parkinson's disease: rationale and current statusNon-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease: evidence from observational studiesNon-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease: evidence from observational studiesImaging of peripheral benzodiazepine receptor expression as biomarkers of detrimental versus beneficial glial responses in mouse models of Alzheimer's and other CNS pathologiesCB2 receptors in the brain: role in central immune functionSelective COX-2 inhibition prevents progressive dopamine neuron degeneration in a rat model of Parkinson's diseaseMicroglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein depositionParkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation.Serum antibodies from Parkinson's disease patients react with neuronal membrane proteins from a mouse dopaminergic cell line and affect its dopamine expressionA Compendium of Preparation and Application of Stem Cells in Parkinson's Disease: Current Status and Future ProspectsTSPO imaging in parkinsonian disordersGenetic and Transcriptomic Profiles of Inflammation in Neurodegenerative Diseases: Alzheimer, Parkinson, Creutzfeldt-Jakob and TauopathiesTargeting New Candidate Genes by Small Molecules Approaching Neurodegenerative DiseasesFriends or Foes: Matrix Metalloproteinases and Their Multifaceted Roles in Neurodegenerative DiseasesNeuroinflammation in Parkinson's disease and its potential as therapeutic targetInsights into Neuroinflammation in Parkinson's Disease: From Biomarkers to Anti-Inflammatory Based TherapiesRelevance of chronic stress and the two faces of microglia in Parkinson's diseaseImmune phenotypes of microglia in human neurodegenerative disease: challenges to detecting microglial polarization in human brainsOxidative stress and Parkinson's diseaseNeuroinflammation in the pathophysiology of Parkinson's disease and therapeutic evidence of anti-inflammatory drugsThe outdoor air pollution and brain health workshopMechanisms of islet amyloidosis toxicity in type 2 diabetesImpact of age-related neuroglial cell responses on hippocampal deteriorationImaging multiple sclerosis and other neurodegenerative diseasesMechanisms of altered redox regulation in neurodegenerative diseases--focus on S--glutathionylationThe role of free radicals in the aging brain and Parkinson's Disease: convergence and parallelismThe complex relationships between microglia, alpha-synuclein, and LRRK2 in Parkinson's diseaseA progressive mouse model of Parkinson's disease: the Thy1-aSyn ("Line 61") miceInflammation, mitochondria, and the inhibition of adult neurogenesisThe role of the immune system in neurodegenerative disorders: Adaptive or maladaptive?Role of prostaglandins in neuroinflammatory and neurodegenerative diseasesUncovering novel actors in astrocyte-neuron crosstalk in Parkinson's disease: the Wnt/β-catenin signaling cascade as the common final pathway for neuroprotection and self-repairInhibition of microglia activation as a phenotypic assay in early drug discoveryPotential benefits of therapeutic use of β2-adrenergic receptor agonists in neuroprotection and Parkinsonμs diseaseVaccination strategies for Parkinson disease: induction of a swift attack or raising tolerance?Inflammation and α-synuclein's prion-like behavior in Parkinson's disease--is there a link?Metabolic syndrome: an important risk factor for Parkinson's diseaseM1 and M2 immune activation in Parkinson's Disease: Foe and ally?
P2860
Q21129356-0D56C3B6-4205-41F3-9629-31F57349D4AAQ21133553-56D8FB79-CD9C-4377-B9F5-EDA0A30897F5Q22241423-F4A5F663-9774-49DF-B2AC-4155BBA8088CQ24235107-B888A746-D080-4F47-95F1-41F2F245738DQ24236199-A8503F52-47B1-426E-8BF4-8EE88C2395A8Q24642726-46F32E97-1827-4325-A2EF-4939CDF0A36EQ24643895-04A1F975-7C34-4753-9490-CC77DD30BB63Q24794457-B809863C-81F7-4A8E-B572-BE7062FD91B8Q24813664-F24F7163-57E2-4746-9798-B4E0AE150A84Q24815148-6BA4BA73-326D-4DAB-8DAF-044F98490279Q25257546-6CB639B3-712F-4F96-AF94-576D0A08B2EEQ26746033-1ADF581F-DC21-4B28-9F14-60DCF015AAC2Q26747214-5315A7BB-313F-4983-B829-FE79AED694CBQ26767289-B335D786-A0FB-40F7-936A-9D1BE47F080FQ26771812-93554472-5A72-4581-98C4-D49532A52A97Q26779933-6A61925A-D7DC-4AE4-AA80-6D0C260B1373Q26783305-94E99D4B-0E2A-4E7A-8528-3CB7DF770D02Q26795984-9DCFFC3D-EEEF-4013-89D9-A66A5A2B679BQ26796241-AD0EFB82-BEA8-411C-9E39-1121302E22F0Q26796857-3D6ABCED-2B34-4063-B13A-7A70F42D9DB2Q26798897-AF286E10-127F-4D63-B79E-E6CA83D32251Q26801035-85157038-EC9D-474C-9ED7-943AE632CEACQ26823021-FFE3D1AE-681F-4795-A9C4-E57E38DE66C6Q26823708-67659CDC-E6E9-4764-B6AE-6EBC362D0ED5Q26825419-53E5F945-DECE-431A-B4E0-763F944E9880Q26826889-0B7A7DCC-8B13-4A0A-91DC-C7EED9193E92Q26830954-E6FDBE4E-FB8D-4CE9-91C9-FD1E7962559CQ26852148-CDCEA770-B5FB-474B-A836-ABBBC1EDE0E7Q26853537-E0F43705-9F93-4BCD-AA46-8F1A0E178C9AQ26859072-ED4B8DC2-D4F4-4849-B653-E0D927A4B3D0Q26860239-D5DD9348-36E6-4C4E-9FBB-EE324621215CQ26861263-A5D0845B-A476-4A11-AF9E-6DA324375032Q26863534-BEB87166-FAA4-49A7-BD99-0C2DA98C703DQ26865502-7AA95E15-BD9E-4D14-A843-0157BE205276Q26996061-C62DF0FB-BD29-4363-AF5F-F8CB1754925CQ27012822-446A6342-33E2-4553-B8E7-8DBAAD3C76A7Q27015811-BC0D766E-8043-4317-B8ED-1B1474535563Q27022728-585EE191-D4DD-4CDF-B0DA-A9B95F4EFBCFQ27023711-7F3489C0-22C1-4FB4-A4C8-962EED2AC174Q27024667-E52BD2FF-4C9E-4A75-9179-2EBB261AFCCE
P2860
Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains
description
1988 nî lūn-bûn
@nan
1988 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Reactive microglia are positiv ...... and Alzheimer's disease brains
@ast
Reactive microglia are positiv ...... and Alzheimer's disease brains
@en
type
label
Reactive microglia are positiv ...... and Alzheimer's disease brains
@ast
Reactive microglia are positiv ...... and Alzheimer's disease brains
@en
prefLabel
Reactive microglia are positiv ...... and Alzheimer's disease brains
@ast
Reactive microglia are positiv ...... and Alzheimer's disease brains
@en
P2093
P921
P3181
P356
P1433
P1476
Reactive microglia are positiv ...... and Alzheimer's disease brains
@en
P2093
P304
P3181
P356
10.1212/WNL.38.8.1285
P407
P577
1988-08-01T00:00:00Z